Back to Market Feed

Historical record - last NADAC effective date: 8/23/2023

Product Information

SUMATRIPTAN-NAPROXEN 85-500 MG is a generic product labeled by Currax Pharmaceuticals LLC, priced at $17.8743 per EA under NDC 44183085009. Its NADAC has been published 272 times since Jul 18, 2018.

FDA first approved this application on Apr 15, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUMATRIPTAN-NAPROXEN 85-500 MG

sumatriptan succinate and naproxen sodium
$17.8743per EA

Strength

500; 85 mg/1; mg/1

NDC

44183085009

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/23/2023

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021926

FDA Approved

4/15/2008

TE Code

AB

On Market Since

5/14/2015

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has been published 272 times since Jul 18, 2018, and over the history we have for it it has declined 63.2%. The table below summarizes its recorded NADAC range and movement.

Current price$17.8743 per EA
All-time high$64.2190 (Nov 14, 2018)
All-time low$14.7549 (Jan 18, 2023)
Median price$32.2535
Average price$34.3990
Largest weekly change+47.6% (May 18, 2022)
Weeks tracked272
Tracking sinceJul 18, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+3.2%

5Y

-16.4%

All

-63.2%

Last surveyed Sep 27, 2023 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the sumatriptan succinate and naproxen sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

MINIPRIN EC 81 MG TABLET
Generic
49483033010•Time-Cap Labs Inc.
$0.0118
per EA
MINIPRIN EC 81 MG TABLET
Generic
49483033012•Time-Cap Labs Inc.
$0.0118
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035203•Chain Drug Marketing Association
$0.0121
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035210•Chain Drug Marketing Association
$0.0121
per EA
ST. JOSEPH ASPIRIN EC 81 MG TB
Generic
69536018112•Foundation Consumer Healthcare LLC
$0.0139
per EA
ASPIRIN EC 81 MG TABLET
Generic
00536123441•Rugby Laboratories
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904675180•Major Pharmaceuticals
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904678370•Major Pharmaceuticals
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059848•AmerisourceBergen
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059887•AmerisourceBergen
$0.0146
per EA

Frequently asked questions

What is the NADAC price of SUMATRIPTAN-NAPROXEN 85-500 MG?

The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN-NAPROXEN 85-500 MG, manufactured by Currax Pharmaceuticals LLC, is $17.8743 per EA (NDC 44183085009), effective Sep 27, 2023.

How has the price of SUMATRIPTAN-NAPROXEN 85-500 MG changed over time?

Over the history we have for it, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has declined 63.2%. It has been tracked across 272 weekly CMS publications since Jul 18, 2018.

What are the highest and lowest recorded NADAC prices for SUMATRIPTAN-NAPROXEN 85-500 MG?

Since Jul 18, 2018, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has ranged from a low of $14.7549 (Jan 18, 2023) to a high of $64.2190 (Nov 14, 2018), with a median of $32.2535 per EA.

Are there cheaper alternatives to SUMATRIPTAN-NAPROXEN 85-500 MG?

No other NADAC-published product currently shares the active ingredient and strength of SUMATRIPTAN-NAPROXEN 85-500 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures SUMATRIPTAN-NAPROXEN 85-500 MG?

SUMATRIPTAN-NAPROXEN 85-500 MG (NDC 44183085009) is labeled by Currax Pharmaceuticals LLC, and CMS classifies it as a generic product.